National Vision Holdings, Inc.
EYENasdaqCIK 1710155HealthcareFiscal year ends Jan 2
Reports and events: 145 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1308:20 ET | 10-Q | Quarterly reportPeriod 2026-07-04 | 0001628280-26-056493 |
| 2026-08-1206:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-055930 |
| 2026-06-2216:11 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-26-044630 |
| 2026-06-0308:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-040046 |
| 2026-05-1408:37 ET | 10-Q | Quarterly reportPeriod 2026-04-04 | 0001628280-26-034824 |
| 2026-05-1306:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-034360 |
| 2026-05-0406:01 ET | DEF 14A | Proxy statementPeriod 2026-06-17 | 0001140361-26-018642 |
| 2026-03-0406:07 ET | 10-K | Annual reportPeriod 2026-01-03 | 0001628280-26-014379 |
| 2026-03-0406:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-014376 |
| 2025-12-1616:30 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-25-121608 |
| 2025-11-0608:23 ET | 10-Q | Quarterly reportPeriod 2025-09-27 | 0001628280-25-049891 |
| 2025-11-0506:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-049201 |
| 2025-08-0708:33 ET | 10-Q | Quarterly reportPeriod 2025-06-28 | 0001710155-25-000047 |
| 2025-08-0606:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001710155-25-000042 |
| 2025-08-0408:22 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001710155-25-000036 |
| 2025-06-2317:04 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001710155-25-000033 |
| 2025-05-0808:36 ET | 10-Q | Quarterly reportPeriod 2025-03-29 | 0001710155-25-000022 |
| 2025-05-0706:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001710155-25-000015 |
| 2025-04-2906:22 ET | DEF 14A | Proxy statementPeriod 2025-06-18 | 0001140361-25-016164 |
| 2025-04-2906:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-040476 |
| 2025-03-1717:00 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-024481 |
| 2025-02-2606:09 ET | 10-K | Annual reportPeriod 2024-12-28 | 0001710155-25-000011 |
| 2025-02-2606:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001710155-25-000009 |
| 2025-01-1616:10 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-004105 |
| 2024-11-0606:20 ET | 10-Q | Quarterly reportPeriod 2024-09-28 | 0001710155-24-000060 |
| 2024-11-0606:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001710155-24-000057 |
| 2024-08-0916:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-087777 |
| 2024-08-0706:29 ET | 10-Q | Quarterly reportPeriod 2024-06-29 | 0001710155-24-000052 |
| 2024-08-0706:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001710155-24-000050 |
| 2024-08-0116:34 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001710155-24-000046 |
| 2024-06-1316:25 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001710155-24-000035 |
| 2024-05-0806:19 ET | 10-Q | Quarterly reportPeriod 2024-03-30 | 0001710155-24-000028 |
| 2024-05-0806:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001710155-24-000026 |
| 2024-04-2506:03 ET | DEF 14A | Proxy statementPeriod 2024-06-12 | 0001104659-24-051446 |
| 2024-02-2706:13 ET | 10-K | Annual reportPeriod 2023-12-30 | 0001710155-24-000018 |
| 2024-02-2706:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001710155-24-000017 |
| 2024-02-0808:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001710155-24-000005 |
| 2023-12-1216:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001710155-23-000063 |
| 2023-11-1307:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001710155-23-000057 |
| 2023-11-0906:05 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001710155-23-000052 |
| 2023-11-0906:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001710155-23-000050 |
| 2023-08-1006:14 ET | 10-Q | Quarterly reportPeriod 2023-07-01 | 0001710155-23-000044 |
| 2023-08-1006:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001710155-23-000043 |
| 2023-07-2616:06 ET | 8-K | 1.02 Termination of a material agreement; 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001710155-23-000038 |
| 2023-06-2008:31 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001710155-23-000033 |
| 2023-05-1106:07 ET | 10-Q | Quarterly reportPeriod 2023-04-01 | 0001710155-23-000023 |
| 2023-05-1106:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001710155-23-000021 |
| 2023-04-2606:03 ET | DEF 14A | Proxy statement | 0001104659-23-049818 |
| 2023-03-1017:45 ET | 8-K | 7.01 Regulation FD disclosure | 0001710155-23-000015 |
| 2023-03-0106:13 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001710155-23-000011 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 13:56 ET. Listed shows no prices and gives no investment advice.